Verwandte Artikel zu Cost-effectiveness analysis of HIV/AIDS "Test and...
Cost-effectiveness analysis of HIV/AIDS "Test and treat" strategy vs. Current treatment guideline in Botswana - Softcover
Zu dieser ISBN ist aktuell kein Angebot verfügbar.
Alle Exemplare der Ausgabe mit dieser ISBN anzeigen:
Reseña del editor:
Seminar paper from the year 2015 in the subject Medicine - Other, Johns Hopkins University, language: English, abstract: A more aggressive strategy "test and treat" is predicted to reduce AIDS-related mortality, increase the life expectancy of people living with HIV and is cost-effective. However, the cost-effectiveness studies related to "test and treat" strategy did not consider the possibility of increased drug resistance due to poor adherence, which is not rare in developing countries. There is a need for a cost-effectiveness analysis related to "test and treat" strategy in developing countries that includes drug resistance as an important parameter. This analysis is to support the government of Botswana to examine the cost-effectiveness of a HIV/AIDS "test and treat" strategy vs. current treatment guideline, which is providing treatment to patients with a CD4 count of <350 cells/ μL.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
- VerlagGRIN Verlag
- Erscheinungsdatum2015
- ISBN 10 3656921652
- ISBN 13 9783656921653
- EinbandTapa blanda
- Auflage2
- Anzahl der Seiten24
Neu kaufen
Mehr zu diesem Angebot erfahren
EUR 17,95
Versand:
EUR 32,99
Von Deutschland nach USA
Beste Suchergebnisse beim ZVAB
Foto des Verkäufers
Cost-effectiveness analysis of HIV/AIDS ¿Test and treat¿ strategy vs. Current treatment guideline in Botswana
Anbieter:
Bewertung
Buchbeschreibung Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Seminar paper from the year 2015 in the subject Medicine - Other, Johns Hopkins University, language: English, abstract: A more aggressive strategy 'test and treat' is predicted to reduce AIDS-related mortality, increase the life expectancy of people living with HIV and is cost-effective. However, the cost-effectiveness studies related to 'test and treat' strategy did not consider the possibility of increased drug resistance due to poor adherence, which is not rare in developing countries. There is a need for a cost-effectiveness analysis related to 'test and treat' strategy in developing countries that includes drug resistance as an important parameter. This analysis is to support the government of Botswana to examine the cost-effectiveness of a HIV/AIDS 'test and treat' strategy vs. current treatment guideline, which is providing treatment to patients with a CD4 count of 350 cells/ miL. Artikel-Nr. 9783656921653
Weitere Informationen zu diesem Verkäufer | Verkäufer kontaktieren
Neu kaufen
EUR 17,95
Währung umrechnen